Which of the following pharmaceutical innovations was the first FDA-approved gene therapy for treating an inherited disease in the United States?

The medical industry constantly evolves through groundbreaking innovations that transform patient care. This trivia question focuses on a revolutionary product innovation that changed how certain conditions are treated. Test your knowledge about significant pharmaceutical breakthroughs and see if you can identify which major innovation disrupted traditional treatment protocols in the last decade.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Luxturna (voretigene neparvovec), approved in 2017 for treating inherited retinal dystrophy
Spinraza (nusinersen), approved in 2016 for treating spinal muscular atrophy
Kymriah (tisagenlecleucel), approved in 2017 as CAR-T therapy for leukemia
Hemlibra (emicizumab), approved in 2017 for treating hemophilia A